Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development and validation of a simple web-based tool for early prediction of COVID-19-associated death in kidney transplant recipients.
Modelli de Andrade LG, de Sandes-Freitas TV, Requião-Moura LR, Viana LA, Cristelli MP, Garcia VD, Alcântara ALC, Esmeraldo RM, Abbud Filho M, Pacheco-Silva A, de Lima Carneiro ECR, Manfro RC, Costa KMAH, Simão DR, de Sousa MV, Santana VBBM, Noronha IL, Romão EA, Zanocco JA, Arimatea GGQ, De Boni Monteiro de Carvalho D, Tedesco-Silva H, Medina-Pestana J; COVID-19-KT Brazil. Modelli de Andrade LG, et al. Among authors: manfro rc. Am J Transplant. 2022 Feb;22(2):610-625. doi: 10.1111/ajt.16807. Epub 2021 Sep 2. Am J Transplant. 2022. PMID: 34416075 Free PMC article.
Protocol biopsies in renal transplant patients: three-years' follow-up.
Veronese FV, Noronha IL, Manfro RC, Edelweiss MI, Goldberg J, Oliveira SG, Oliveira IB, Leitão TG, Gonçalves LF. Veronese FV, et al. Among authors: manfro rc. Transplant Proc. 2002 Mar;34(2):500-1. doi: 10.1016/s0041-1345(02)02608-8. Transplant Proc. 2002. PMID: 12009604 No abstract available.
Occult hepatitis B in renal transplant patients.
Peres AA, Dias EA, Chesky M, Alvares-da-Silva MR, Jobim LF, Gonçalves LF, Manfro RC. Peres AA, et al. Among authors: manfro rc. Transpl Infect Dis. 2005 Jun;7(2):51-6. doi: 10.1111/j.1399-3062.2005.00091.x. Transpl Infect Dis. 2005. PMID: 16150090
Comparison of the safety and efficacy of cyclosporine minimization versus cyclosporine elimination in de novo renal allograft patients receiving sirolimus.
Tedesco-Silva H, Garcia VD, Contieri FL, De Boni Monteiro de Carvalho D, Noronha IL, Gonçalves RT, de Paula FJ, Abbud-Filho M, Manfro RC, David-Neto E, Alfieri F, Ikehara E, Jiang Q, Tai SS, Medina-Pestana JO. Tedesco-Silva H, et al. Among authors: manfro rc. Transplant Proc. 2010 Jun;42(5):1659-66. doi: 10.1016/j.transproceed.2010.02.083. Transplant Proc. 2010. PMID: 20620495 Clinical Trial.
Three-year outcomes from BENEFIT-EXT: a phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneys.
Pestana JO, Grinyo JM, Vanrenterghem Y, Becker T, Campistol JM, Florman S, Garcia VD, Kamar N, Lang P, Manfro RC, Massari P, Rial MD, Schnitzler MA, Vitko S, Duan T, Block A, Harler MB, Durrbach A. Pestana JO, et al. Among authors: manfro rc. Am J Transplant. 2012 Mar;12(3):630-9. doi: 10.1111/j.1600-6143.2011.03914.x. Epub 2012 Feb 2. Am J Transplant. 2012. PMID: 22300431 Free article. Clinical Trial.
152 results